Pablo Maggiani Aguilera

Dr. Pablo Maggiani Aguilera


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JCJonathan Samuel Chávez-Iñiguez
Jonathan Samuel Chávez-Iñiguez
RMRamón Medina-Gonzalez
Ramón Medina-Gonzalez
LALilia Aguilar-Parra
Lilia Aguilar-Parra
ETEduardo J. Torres-Vázquez
Eduardo J. Torres-Vázquez
PAPablo Maggiani Aguilera
Pablo Maggiani Aguilera
Guillermo Garcia-GarciaGuillermo Garcia-Garcia
Guillermo Garcia-Garcia
Acyclovir is one of the most common prescribed antiviral drugs. Acyclovir nephrotoxicity occurs in approximately 12–48% of cases. It can present in clinical practice as acute kidney injury (AKI), crystal-induced nephropathy, acute tubulointerstitial nephritis, and rarely, as tubular dysfunction. Electrolytes abnormalities like hypokalemia, were previously described only when given intravenously. A 54 year-old female presented with weakness and lower extremities paresis, nausea and vomiting after receiving oral acyclovir. Physical examination disclosed a decrease in the patellar osteotendinous reflexes (++ / ++++). Laboratory data showed a serum creatinine level of 2.1 mg/dL; serum potassium 2.1 mmol/L. Kidney biopsy was obtained; histological findings were consistent with acute tubular necrosis and acute tubulointerstitial nephritis. The patient was advised to stop the medications and to start with oral and intravenous potassium supplement, symptoms improved and continued until serum potassium levels were > 3.5 meq/L. The case reported in this vignette is unique since it is the first one to describe hypokalemia associated to acute tubular necrosis induced by oral acyclovir.